StockData

BGM Group Ltd. (BGM) stock

BGMNasdaqPharmaceutical PreparationsFiscal year ends September 30
Financials through fiscal 2025, year ended Sep 30, 2025Last filing: 20-F on Jul 21, 2026Score 9/30
$8.01+0.13 (+1.71%)

Close on Nov 16, 2026Market cap $3.21BP/E –Yield –

BGM EPS

Diluted earnings per share is net income divided by the share count including options and convertible securities.

For fiscal 2025 it was -$0.18. The highest annual figure on record is $0.90 in fiscal 2019.

Annual eps

PeriodPeriod endValueChange
FY2025Sep 30, 2025-$0.18–
FY2024Sep 30, 2024-$0.20–
FY2023Sep 30, 2023-$1.08-820.0%
FY2022Sep 30, 2022$0.15-66.7%
FY2021Sep 30, 2021$0.45-47.1%
FY2020Sep 30, 2020$0.85-5.6%
FY2019Sep 30, 2019$0.90+5.9%
FY2018Sep 30, 2018$0.85–

More BGM figures

See a number that looks wrong?